Clinical Trial Update: Patient-Reported Outcomes of Benralizumab in Real-World Use in Severe Eosinophilic Asthma Patients in Taiwan (BEAT)

View source ↗

Summary

This clinical trial update reports patient-reported outcomes from real-world use of benralizumab in Taiwanese patients with severe eosinophilic asthma; the BEAT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED